MDMA (Ecstacy): Useful Information for Health Professionals Involved in Drug Education Programs
Journal of Drug Education December 1, 1996 DOI: 10.2190/k2pl-q2yf-wng0-54qd (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Population | Adolescents and young adults |
| Topics | MDMA |
| Keywords | Amphetamine Drug education Hallucinogen Limiting Curriculum Pharmacology |
| Citations | 22 |
| Key points | Systematic scientific information concerning MDMA and its effects is insufficient, limiting its inclusion in drug education curricula. |
Abstract
3,4-Methylenedioxymethamphetamine (MDMA; “Ecstacy”) is an amphetamine derivative that is related chemically to both amphetamines and hallucinogens. Despite reports of an increase in MDMA usage among adolescents and young adults in the past decade, systematic scientific information concerning MDMA and its effects remains insufficient, thus limiting or eliminating MDMA from inclusion in the drug education curriculum.
Citations in the library
Cited by 2
Cites 4
- Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug British Journal of Addiction August 1, 1992
- Neuroendocrine and Mood Responses to Intravenous L-Tryptophan in 3,4-Methylenedioxymethamphetamine (MDMA) Users Archives of General Psychiatry 1989
- ECSTACY: A Review of MDMA and MDA The International Journal of Psychiatry in Medicine December 1, 1987
- Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacology, Biochemistry, and Behavior December 1988